摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-疏基-5-磺酰基苯并咪唑钾 | 58089-27-3

中文名称
2-疏基-5-磺酰基苯并咪唑钾
中文别名
——
英文名称
2-mercapto-5-benzimidazolesulfonic acid
英文别名
H3MBZD;2-sulfanyl-1H-benzimidazole-5-sulfonic acid;2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonic acid
2-疏基-5-磺酰基苯并咪唑钾化学式
CAS
58089-27-3
化学式
C7H6N2O3S2
mdl
MFCD00192260
分子量
230.268
InChiKey
LLOAINVMNYBDNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    119
  • 氢给体数:
    3
  • 氢受体数:
    4

SDS

SDS:f29f54aa103190f88d8fa3c54184af01
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-5-硝基噻唑2-疏基-5-磺酰基苯并咪唑钾sodium methylate盐酸 作用下, 以 甲醇 为溶剂, 反应 16.0h, 生成 BI-87H1
    参考文献:
    名称:
    Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors
    摘要:
    A new series of 2-thioether-benzothiazoles has been synthesized and evaluated for JNK inhibition. The SAR studies led to the discovery of potent, allosteric JNK inhibitors with selectivity against p38. (c) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.02.046
点击查看最新优质反应信息

文献信息

  • [EN] TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS<br/>[FR] ADMINISTRATION CIBLÉE D'UN MÉDICAMENT FAISANT APPEL À DES COUPLEURS FONDÉS SUR L'AFFINITÉ
    申请人:INVICTUS ONCOLOGY PVT LTD
    公开号:WO2015148126A1
    公开(公告)日:2015-10-01
    The current invention discloses targeted drug delivery conjugates comprising a targeting moiety linked to a drug via a molecule having an affinity for the targeting moiety. Typically, the conjugate comprises a targeting ligand and a molecule of interest, e.g., a therapeutic agent. The targeting ligand and the molecule of interest are linked to each other via an affinity ligand. The affinity ligand is further covalently or non-covalently linked to a drug or therapeutic agent. The drug can be modified to make it more soluble and so that it cleaves from the linking molecule at the target site.
    当前的发明揭示了包括通过具有与靶向基团亲和力的分子连接到药物的靶向药物传递共轭物。通常,该共轭物包括一个靶向配体和一个感兴趣的分子,例如,一个治疗剂。靶向配体和感兴趣的分子通过一个亲和配体相互连接。该亲和配体进一步以共价或非共价方式连接到药物或治疗剂。药物可以被修改以使其更溶解,并使其在靶点处从连接分子中解离。
  • Instant degradation of plastics into soluble non-toxic products
    申请人:——
    公开号:US20020156333A1
    公开(公告)日:2002-10-24
    The present invention describes novel, cost-effective and rapid processes suitable for degradation and recycling of specially designed plastics, which are defined as instantly degradable synthetic polymeric plastics having the characteristics and properties of conventional forms of plastics. These novel plastic products are made from a variety of compositions of polymers and their compatible nontoxic modifiers. The resulting novel instant degradable plastic products retain latent solubility properties which are triggered upon mild chemical processes of the present invention, thus enabling cost effective and facile recycling of plastic refuge.
    本发明描述了一种新颖、具有成本效益且快速的过程,适用于降解和回收特殊设计的塑料,这些塑料被定义为具有传统塑料形式特征和属性的即降解合成聚合塑料。这些新颖的塑料产品由多种聚合物组成及其相容的无毒改性剂制成。由此产生的新型即降解塑料产品保留了潜在的溶解性能,这些性能在本发明的温和化学过程中被触发,从而实现了对塑料废料的成本效益和便捷回收。
  • LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING PROCESS
    申请人:OOHASHI Hidekazu
    公开号:US20110054212A1
    公开(公告)日:2011-03-03
    A lithographic printing plate precursor, which comprises: a support; an image-recording layer; and a protective layer, in this order, wherein at least one of the image-recording layer and the protective layer comprises a phosphonium salt having a specific structure, and a lithographic printing process, which comprises: exposing a lithographic printing plate precursor; supplying an oil-based ink and a fountain solution comprising a phosphonium salt having a specific structure to the exposed lithographic printing plate precursor on a printing machine to remove an unexposed area of an image-recording layer; and conducting printing.
    一种光刻印刷版前体,包括:支撑体;图像记录层;以及保护层,依次排列,其中图像记录层和保护层中至少有一层包含具有特定结构的磷酸铵盐;以及一种光刻印刷工艺,包括:曝光光刻印刷版前体;在印刷机上向曝光的光刻印刷版前体提供具有特定结构的磷酸铵盐的油墨和喷泉溶液,以去除图像记录层中未曝光区域;进行印刷。
  • Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors
    作者:Edgar Specker、Susann Matthes、Radoslaw Wesolowski、Anja Schütz、Maik Grohmann、Natalia Alenina、Dirk Pleimes、Keven Mallow、Martin Neuenschwander、Angelina Gogolin、Marie Weise、Jochen Pfeifer、Nandor Ziebart、Udo Heinemann、Jens Peter von Kries、Marc Nazaré、Michael Bader
    DOI:10.1021/acs.jmedchem.2c00598
    日期:2022.8.25
    this disease. Here, we describe a novel class of potent tryptophan hydroxylase inhibitors, characterized by spanning all active binding sites important for catalysis, specifically those of the cosubstrate pterin, the substrate tryptophan as well as directly chelating the catalytic iron ion. The inhibitors were designed to efficiently reduce serotonin in the periphery while not passing the blood–brain
    色氨酸羟化酶催化血清素合成的第一步和限速步骤。5-羟色胺是中枢神经系统中的一种关键神经递质,在外周,作为具有多种生理功能的局部激素发挥作用。对转基因小鼠模型的研究表明,外周血清素水平的失调会导致代谢、炎症和纤维化疾病。肿瘤细胞过度产生血清素会导致类癌综合征典型的严重症状,色氨酸羟化酶抑制剂已经在临床上用于患有这种疾病的患者。在这里,我们描述了一类新的强效色氨酸羟化酶抑制剂,其特征在于跨越所有对催化重要的活性结合位点,特别是那些共底物蝶呤,底物色氨酸以及直接螯合催化铁离子。这些抑制剂旨在有效减少外周的血清素,同时不通过血脑屏障,从而保持大脑中的血清素水平。
  • [EN] ANTIMICROBIAL SILVER COORDINATION COMPLEXES<br/>[FR] COMPLEXES DE COORDINATION D'ARGENT ANTIMICROBIENS
    申请人:PENTA SCIENCE IND HOLDING B V
    公开号:WO2021209134A1
    公开(公告)日:2021-10-21
    An anionic bi-coordinated silver (I) complex has antimicrobial activity and the general formula [Ag+(L2-)2]3-, wherein L2- is a ligand selected from the group consisting of 2- mercapto-4-methyl-5-thiazole acetate, 3-mercapto-1-propansulfonate, 2-mercapto-5-5 benzimidazole sulfonate and thiosalicylate. A sodium salt of the aforesaid anionic bi- coordinated silver (I) complex has antimicrobial activity and the general formula Na+3[Ag+(L2-)2]3-. A salt of the aforesaid anionic bi-coordinated silver (I) complex has antimicrobial activity and the general formula (W+)3[Ag+(L2-)2]n, wherein W+ is a cationic surface-active agent, selected from the group consisting of octenidine, chlorhexidine, benzalkonium and didecyldimethylammonium; n is 2 when W+ is octenidine or chlorhexidine; n is 1 when W+ is benzalkonium or didecyldimethylammonium. The anionic bi-coordinated silver (I) complex can be incorporated in an antimicrobial gel containing sodium hyaluronate and sodium ascorbyl phosphate. The antimicrobial gel is thermally and photochemically stable and is suitable for medical use; in particular, it may be used as a liquid bandage. The complex-containing salts show high affinity for solid surfaces and can be adsorbed on solid surfaces, thus enabling to formulate antimicrobial coatings and powders.
    一种阴离子双配位银(I)配合物具有抗微生物活性,其通式为[Ag+(L2-)2]3-,其中L2-为从2-巯基-4-甲基-5-噻唑乙酸盐、3-巯基-1-丙磺酸盐、2-巯基-5-5-苯并咪唑磺酸盐和硫代水杨酸组成的配体之一。上述阴离子双配位银(I)配合物的钠盐具有抗微生物活性,其通式为Na+3[Ag+(L2-)2]3-。上述阴离子双配位银(I)配合物的盐具有抗微生物活性,其通式为(W+)3[Ag+(L2-)2]n,其中W+为从辛甘汀、氯己定、苯扎氯铵和二十二烷基二甲基溴化铵组成的阳离子表面活性剂之一;当W+为辛甘汀或氯己定时,n为2;当W+为苯扎氯铵或二十二烷基二甲基溴化铵时,n为1。该阴离子双配位银(I)配合物可被纳入含有透明质酸钠和磷酸抗坏血酸钠的抗微生物凝胶中。该抗微生物凝胶具有热稳定性和光化学稳定性,适用于医疗用途;特别是,它可以用作液体创口贴。含有该配合物的盐对固体表面具有高亲和力,可以被吸附在固体表面上,从而可以制备抗微生物涂层和粉末。
查看更多